IQVIA HOLDINGS INC. Goodwill, Acquired During Period
IQVIA HOLDINGS INC. (IQV) reported Goodwill, Acquired During Period of $30.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Notes › Goodwill and Other
us-gaap:GoodwillAcquiredDuringPeriod · last filed 2026-05-05
- IQVIA HOLDINGS INC. goodwill, acquired during period for the quarter ending 2026-03-31 was $30.00M, a 69.39% decline year-over-year.
- IQVIA HOLDINGS INC. goodwill, acquired during period for the quarter ending 2025-12-31 was $683.00M, a 1001.61% increase year-over-year.
- IQVIA HOLDINGS INC. goodwill, acquired during period for the quarter ending 2025-09-30 was $360.00M, a 11.46% increase year-over-year.
- IQVIA HOLDINGS INC. goodwill, acquired during period for the quarter ending 2025-06-30 was $138.00M, a 213.64% increase year-over-year.
- IQVIA HOLDINGS INC. goodwill, acquired during period for fiscal 2025 was $1.28B, a 140.41% increase from fiscal 2024.
- IQVIA HOLDINGS INC. goodwill, acquired during period for fiscal 2024 was $532.00M, a 0.19% decline from fiscal 2023.
- IQVIA HOLDINGS INC. goodwill, acquired during period for fiscal 2023 was $533.00M, a 48.05% decline from fiscal 2022.
- IQVIA HOLDINGS INC. goodwill, acquired during period for fiscal 2022 was $1.03B, a 3.21% decline from fiscal 2021.
| Period end | Goodwill, Acquired During Period 3 month | Goodwill, Acquired During Period 6 month | Goodwill, Acquired During Period 9 month | Goodwill, Acquired During Period 12 month | Goodwill, Acquired During Period 12 month as first filed |
|---|---|---|---|---|---|
| 2026-03-31 | $30.00M 10-Q · filed 2026-05-05 | $713.00M derived: sum of 2 quarters · filed 2026-05-05 | $1.07B derived: sum of 3 quarters · filed 2026-05-05 | $1.21B derived: sum of 4 quarters · filed 2026-05-05 | |
| 2025-12-31 | $683.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $1.04B derived: sum of 2 quarters · filed 2026-02-17 | $1.18B derived: sum of 3 quarters · filed 2026-02-17 | $1.28B 10-K · filed 2026-02-17 | |
| 2025-09-30 | $360.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $498.00M derived: sum of 2 quarters · filed 2025-10-28 | $596.00M 10-Q · filed 2025-10-28 | $658.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2025-06-30 | $138.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | $236.00M 10-Q · filed 2025-07-22 | $298.00M derived: sum of 3 quarters · filed 2026-02-17 | $621.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2025-03-31 | $98.00M 10-Q · filed 2025-05-06 | $160.00M derived: sum of 2 quarters · filed 2026-02-17 | $483.00M derived: sum of 3 quarters · filed 2026-02-17 | $527.00M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-12-31 | $62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $385.00M derived: sum of 2 quarters · filed 2026-02-17 | $429.00M derived: sum of 3 quarters · filed 2026-02-17 | $532.00M 10-K · filed 2026-02-17 | |
| 2024-09-30 | $323.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $367.00M derived: sum of 2 quarters · filed 2024-10-31 | $470.00M 10-Q · filed 2024-10-31 | $491.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2024-06-30 | $44.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-22 | $147.00M 10-Q · filed 2024-07-22 | $168.00M derived: sum of 3 quarters · filed 2025-02-13 | $445.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2024-03-31 | $103.00M 10-Q · filed 2024-05-02 | $124.00M derived: sum of 2 quarters · filed 2025-02-13 | $401.00M derived: sum of 3 quarters · filed 2025-02-13 | $618.00M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $298.00M derived: sum of 2 quarters · filed 2025-02-13 | $515.00M derived: sum of 3 quarters · filed 2025-02-13 | $533.00M 10-K · filed 2025-02-13 | |
| 2023-09-30 | $277.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $494.00M derived: sum of 2 quarters · filed 2023-11-01 | $512.00M 10-Q · filed 2023-11-01 | $799.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2023-06-30 | $217.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $235.00M 10-Q · filed 2023-08-01 | $522.00M derived: sum of 3 quarters · filed 2024-02-15 | $952.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2023-03-31 | $18.00M 10-Q · filed 2023-04-28 | $305.00M derived: sum of 2 quarters · filed 2024-02-15 | $735.00M derived: sum of 3 quarters · filed 2024-02-15 | $705.00M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-12-31 | $287.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $717.00M derived: sum of 2 quarters · filed 2024-02-15 | $687.00M derived: sum of 3 quarters · filed 2024-02-15 | $1.03B 10-K · filed 2024-02-15 | |
| 2022-09-30 | $430.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $400.00M derived: sum of 2 quarters · filed 2022-10-27 | $739.00M 10-Q · filed 2022-10-27 | $1.03B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2022-06-30 | -$30.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22 | $309.00M 10-Q · filed 2022-07-22 | $597.00M derived: sum of 3 quarters · filed 2023-02-15 | $1.30B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2022-03-31 | $339.00M 10-Q · filed 2022-04-28 | $627.00M derived: sum of 2 quarters · filed 2023-02-15 | $1.33B derived: sum of 3 quarters · filed 2023-02-15 | $1.38B derived: sum of 4 quarters · filed 2023-02-15 | |
| 2021-12-31 | $288.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $992.00M derived: sum of 2 quarters · filed 2023-02-15 | $1.04B derived: sum of 3 quarters · filed 2023-02-15 | $1.06B 10-K · filed 2023-02-15 | |
| 2021-09-30 | $704.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-22 | $757.00M derived: sum of 2 quarters · filed 2021-10-22 | $772.00M 10-Q · filed 2021-10-22 | $803.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2021-06-30 | $53.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $68.00M 10-Q · filed 2021-07-28 | $99.00M derived: sum of 3 quarters · filed 2022-02-16 | $113.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2021-03-31 | $15.00M 10-Q · filed 2021-04-23 | $46.00M derived: sum of 2 quarters · filed 2022-02-16 | $60.00M derived: sum of 3 quarters · filed 2022-02-16 | $118.00M derived: sum of 4 quarters · filed 2022-02-16 | |
| 2020-12-31 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $45.00M derived: sum of 2 quarters · filed 2022-02-16 | $103.00M derived: sum of 3 quarters · filed 2022-02-16 | $115.00M 10-K · filed 2022-02-16 | |
| 2020-09-30 | $14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-22 | $72.00M derived: sum of 2 quarters · filed 2020-10-22 | $84.00M 10-Q · filed 2020-10-22 | $187.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2020-06-30 | $58.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23 | $70.00M 10-Q · filed 2020-07-23 | $173.00M derived: sum of 3 quarters · filed 2021-02-12 | $361.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2020-03-31 | $12.00M 10-Q · filed 2020-04-30 | $115.00M derived: sum of 2 quarters · filed 2021-02-12 | $303.00M derived: sum of 3 quarters · filed 2021-02-12 | $323.00M derived: sum of 4 quarters · filed 2021-02-12 | |
| 2019-12-31 | $103.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $291.00M derived: sum of 2 quarters · filed 2021-02-12 | $311.00M derived: sum of 3 quarters · filed 2021-02-12 | $436.00M 10-K · filed 2021-02-12 | |
| 2019-09-30 | $188.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $208.00M derived: sum of 2 quarters · filed 2019-11-01 | $333.00M 10-Q · filed 2019-11-01 | $377.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2019-06-30 | $20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $145.00M 10-Q · filed 2019-07-24 | $189.00M derived: sum of 3 quarters · filed 2020-02-18 | $213.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2019-03-31 | $125.00M 10-Q · filed 2019-05-02 | $169.00M derived: sum of 2 quarters · filed 2020-02-18 | $193.00M derived: sum of 3 quarters · filed 2020-02-18 | $320.00M derived: sum of 4 quarters · filed 2020-02-18 | |
| 2018-12-31 | $44.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $68.00M derived: sum of 2 quarters · filed 2020-02-18 | $195.00M derived: sum of 3 quarters · filed 2020-02-18 | $202.00M 10-K · filed 2020-02-18 | |
| 2018-09-30 | $24.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $151.00M derived: sum of 2 quarters · filed 2018-10-25 | $158.00M 10-Q · filed 2018-10-25 | $349.00M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2018-06-30 | $127.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $134.00M 10-Q · filed 2018-07-27 | $325.00M derived: sum of 3 quarters · filed 2019-02-19 | $501.00M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2018-03-31 | $7.00M 10-Q · filed 2018-05-04 | $198.00M derived: sum of 2 quarters · filed 2019-02-19 | $374.00M derived: sum of 3 quarters · filed 2019-02-19 | $496.00M derived: sum of 4 quarters · filed 2019-02-19 | |
| 2017-12-31 | $191.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $367.00M derived: sum of 2 quarters · filed 2019-02-19 | $489.00M derived: sum of 3 quarters · filed 2019-02-19 | $581.00M 10-K · filed 2019-02-19 | |
| 2017-09-30 | $176.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $298.00M derived: sum of 2 quarters · filed 2017-10-27 | $390.00M 10-Q · filed 2017-10-27 | ||
| 2017-06-30 | $122.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $214.00M 10-Q · filed 2017-08-04 | |||
| 2017-03-31 | $92.00M 10-Q · filed 2017-05-08 | ||||
| 2016-12-31 | $10.38B 10-K · filed 2017-02-16 | ||||
| 2015-12-31 | $10.11B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $10.38B 10-K · filed 2018-02-16 | $262.38M 10-K · filed 2016-02-11 | ||
| 2015-09-30 | $263.86M 10-Q · filed 2015-10-28 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $62.78M 10-K · filed 2016-02-11 | |||
| 2014-09-30 | $62.78M 10-Q · filed 2014-10-30 | ||||
| 2013-12-31 | $296.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $116.54M 10-K · filed 2015-02-12 | |||
| 2013-09-30 | $116.25M 10-Q · filed 2013-10-31 | ||||
| 2012-12-31 | $28.20M 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |